Non-targeted metabonomic analysis of plasma in patients with atherosclerosis by liquid chromatography-mass spectrometry
Authors:
Open Access
- 1 February 2022
- journal article
- research article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (3) , 133
Abstract
Non-targeted metabonomic analysis of plasma in patients with atherosclerosis by liquid chromatography-mass spectrometry Xianru Xia, Xiandong Li, Fei Xie, Guolin Yuan, Dongliang Cheng, Chunyan PengKeywords
This publication has 36 references indexed in Scilit:
- Positive correlation between variants of lipid metabolism-related genes and coronary heart diseaseMolecular Medicine Reports, 2013
- Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular DiseasesCirculation, 2012
- Cytokines, macrophage lipid metabolism and foam cells: Implications for cardiovascular disease therapyProgress in Lipid Research, 2011
- De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid SaturationCancer Research, 2010
- α-Linolenic acid protects renal cells against palmitic acid lipotoxicity via inhibition of endoplasmic reticulum stressEuropean Journal of Pharmacology, 2009
- Risk factors for cardiovascular disease in womenMaturitas, 2009
- Application of Metabolomics to Cardiovascular Biomarker and Pathway DiscoveryJACC, 2008
- Liquid Chromatography Tandem-mass Spectrometry (LC-MS/MS) - Technique and Applications in EndocrinologyExperimental and Clinical Endocrinology & Diabetes, 2007
- The Role of Risk Factors in the Development of AtherosclerosisCritical Reviews in Clinical Laboratory Sciences, 2001
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999